A phase II trial of biweekly vinorelbine and oxaliplatin in second- or third-line metastatic triple-negative breast cancer

Patients with metastatic triple-negative breast cancer (mTNBC) typically have a poor prognosis. The purpose of this study was to prospectively evaluate the efficacy and toxicity of biweekly combination of vinorelbine and oxaliplatin (NVBOX) in second- or third-line setting for mTNBC. Eligible patien...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Cancer Biol Ther
Main Authors: Zhang, Jian, Wang, Leiping, Wang, Zhonghua, Hu, Xichun, Wang, Biyun, Cao, Jun, Lv, Fangfang, Zhen, Chunlei, Zhang, Sheng, Shao, Zhimin
Format: Artigo
Jezik:Inglês
Izdano: Taylor & Francis 2015
Teme:
Clinical Studies
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4622533/
https://ncbi.nlm.nih.gov/pubmed/25648299
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/15384047.2014.986973
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki